• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinoma.

作者信息

Cosgarea Ioana, Lovric Zdenka, Körber Andreas, Dissemond Joachim

机构信息

Department of Dermatology, Venerology and Allergology, University of Essen, Essen, Germany.

出版信息

Int Wound J. 2016 Oct;13(5):1041-2. doi: 10.1111/iwj.12377. Epub 2014 Oct 8.

DOI:10.1111/iwj.12377
PMID:25294697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7949558/
Abstract
摘要

相似文献

1
Successful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinoma.仅在肾细胞癌切除术后使用乌司奴单抗成功治疗难治性坏疽性脓皮病。
Int Wound J. 2016 Oct;13(5):1041-2. doi: 10.1111/iwj.12377. Epub 2014 Oct 8.
2
Ustekinumab in a patient with pyoderma gangrenosum and refractory Crohn's disease.优特克单抗治疗坏疽性脓皮病合并难治性克罗恩病1例
Med Clin (Barc). 2019 Oct 25;153(8):e35-e36. doi: 10.1016/j.medcli.2018.12.004. Epub 2019 Feb 19.
3
Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab.用优特克单抗治疗重度顽固性坏疽性脓皮病。
Australas J Dermatol. 2018 May;59(2):131-134. doi: 10.1111/ajd.12744. Epub 2017 Dec 4.
4
Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.一名克罗恩病患者的难治性坏疽性脓皮病：对优特克单抗完全缓解
J Crohns Colitis. 2019 May 27;13(6):812-813. doi: 10.1093/ecco-jcc/jjy200.
5
Pyoderma gangrenosum solved by ustekinumab therapy.乌司奴单抗治疗使坏疽性脓皮病得到缓解。
Gastroenterol Hepatol. 2021 Apr;44(4):299-300. doi: 10.1016/j.gastrohep.2020.06.027. Epub 2020 Oct 14.
6
Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.用乌司奴单抗成功治疗的伴有溃疡性结肠炎的坏疽性脓皮病
Actas Dermosifiliogr (Engl Ed). 2019 Nov;110(9):776-778. doi: 10.1016/j.ad.2018.03.034. Epub 2019 May 28.
7
Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.在用阿达木单抗治疗银屑病期间出现的坏疽性脓皮病：优特克单抗的有效性。
Australas J Dermatol. 2017 Nov;58(4):e270-e271. doi: 10.1111/ajd.12545. Epub 2017 Jun 28.
8
Successful treatment with ustekinumab and vacuum-assisted closure therapy in recalcitrant myelodysplastic syndrome-associated pyoderma gangrenosum: case report and literature review.优特克单抗与负压封闭引流疗法成功治疗难治性骨髓增生异常综合征相关坏疽性脓皮病：病例报告及文献综述
Clin Exp Dermatol. 2019 Jan;44(1):116-119. doi: 10.1111/ced.13679. Epub 2018 May 30.
9
[Infliximab treatment of peristomal pyoderma gangrenosum in ulcerative colitis].[英夫利昔单抗治疗溃疡性结肠炎造口周围坏疽性脓皮病]
Ugeskr Laeger. 2005 Aug 8;167(32):2920-1.
10
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes.乌司奴单抗作为所有坏疽性脓皮病亚型的辅助治疗。
J Dermatolog Treat. 2022 Jun;33(4):2386-2390. doi: 10.1080/09546634.2021.1937475. Epub 2021 Jun 14.

引用本文的文献

1
The Pathophysiology and Treatment of Pyoderma Gangrenosum-Current Options and New Perspectives.坏疽性脓皮病的发病机制和治疗：现有选择和新视角。
Int J Mol Sci. 2024 Feb 19;25(4):2440. doi: 10.3390/ijms25042440.
2
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.乌司奴单抗在非适应证皮肤科疾病中的其他用途：系统评价。
Arch Dermatol Res. 2022 Aug;314(6):503-514. doi: 10.1007/s00403-021-02262-7. Epub 2021 Jun 22.
3
Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.采用负压伤口治疗和植皮（包括异种移植物）治疗坏疽性脓皮病的手术治疗：161 例的个人经验和综合回顾。
Adv Wound Care (New Rochelle). 2020 Jul;9(7):405-425. doi: 10.1089/wound.2020.1160. Epub 2020 Apr 28.
4
Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis.优特克单抗治疗银屑病和银屑病关节炎。
Rheumatol Ther. 2015 Jun;2(1):1-16. doi: 10.1007/s40744-015-0010-2. Epub 2015 Mar 17.
5
[Pyoderma gangrenosum].[坏疽性脓皮病]
Hautarzt. 2016 Sep;67(9):753-63. doi: 10.1007/s00105-016-3847-6.
6
Pyoderma gangrenosum: challenges and solutions.坏疽性脓皮病：挑战与解决方案
Clin Cosmet Investig Dermatol. 2015 May 28;8:285-93. doi: 10.2147/CCID.S61202. eCollection 2015.

本文引用的文献

1
Treating inflammation by blocking interleukin-1 in humans.通过阻断白细胞介素-1 治疗人类炎症。
Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23.
2
Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients.德国坏疽性脓皮病患者的相关因素和合并症：259 例回顾性多中心分析。
Orphanet J Rare Dis. 2013 Sep 8;8:136. doi: 10.1186/1750-1172-8-136.
3
Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab.使用乌司奴单抗成功治疗严重顽固性坏疽性脓皮病。
J Am Acad Dermatol. 2012 Nov;67(5):e237-8. doi: 10.1016/j.jaad.2012.04.045.
4
Investigation of new co-factors in 49 patients with pyoderma gangrenosum.对 49 例坏疽性脓皮病患者新合并症的调查。
J Dtsch Dermatol Ges. 2012 Apr;10(4):251-7. doi: 10.1111/j.1610-0387.2011.07734.x. Epub 2011 Jul 15.
5
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.白细胞介素23在坏疽性脓皮病中的表达及乌司奴单抗靶向治疗
Arch Dermatol. 2011 Oct;147(10):1203-5. doi: 10.1001/archdermatol.2011.168. Epub 2011 Jun 16.
6
Clinical features of pyoderma gangrenosum and current diagnostic trends.坏疽性脓皮病的临床特征和当前的诊断趋势。
J Am Acad Dermatol. 2011 May;64(5):950-4. doi: 10.1016/j.jaad.2010.01.049. Epub 2011 Feb 3.
7
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.英夫利昔单抗治疗坏疽性脓皮病：一项随机、双盲、安慰剂对照试验。
Gut. 2006 Apr;55(4):505-9. doi: 10.1136/gut.2005.074815. Epub 2005 Sep 27.
8
Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients.坏疽性脓皮病的治疗建议：基于350多名患者的文献循证综述
J Am Acad Dermatol. 2005 Aug;53(2):273-83. doi: 10.1016/j.jaad.2004.10.006.
9
Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria.坏疽性脓皮病：临床病理相关性及拟诊标准
Int J Dermatol. 2004 Nov;43(11):790-800. doi: 10.1111/j.1365-4632.2004.02128.x.
10
Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway.吡啉与PSTPIP1/CD2BP1蛋白结合，将家族性地中海热和PAPA综合征定义为同一通路中的疾病。
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13501-6. doi: 10.1073/pnas.2135380100. Epub 2003 Oct 31.